CARLSBAD, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced the closing of its initial public offering of 10,147,058 shares of common stock, which includes the exercise in full of the underwriters’ option to purchase 1,323,529 additional
CARLSBAD, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (NASDAQ: AFIB) today announced the pricing of its initial public offering of 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus.
ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote TeleRobotic Support. Dr. Gery Tomassoni of Baptist Health in Lexington, KY treated the patient
A New Strategic Alliance Between BIOTRONIK, A Leader In Cardiac Rhythm Management, and Acutus Medical, Electrophysiology Innovator, Expected to Offer More Efficient and Effective Diagnosis and Treatment for Arrhythmia Patients CARLSBAD, California, and BERLIN, Germany, May 20, 2020 – Acutus Medical
Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber – Leading to Rapid, Efficient and Individualized Ablation Strategies Carlsbad, Calif., February 18, 2020 – Acutus Medical today announced FDA clearance and CE Mark of SuperMap – a revolutionary
Groundbreaking Software Provides Unparalleled Rhythm Insight In Less Than Three Minutes Carlsbad, California and Washington D.C., January 23, 2020 — Acutus Medical’s next mission is confirmed: AF Symposium, January 23-25, in Washington, D.C. Mission: Possible will highlight Acutus’ continued
The companies aim to solve the conundrum of stagnated clinical outcomes coupled with increasing costs through a partnership that offers hospitals Acutus’ revolutionary technology together with regulated reprocessing of single-use devices. CARLSBAD, Calif.
AcQMap® Advances Outcomes Toward Atrial Fibrillation Freedom Carlsbad, Calif., July 11, 2019 — Acutus Medical today announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology . The study demonstrated 73 percent single-procedure freedom from atrial
Huennekens Brings Deep Industry Expertise to Help Accelerate Commercialization and Market Expansion Efforts Carlsbad, Calif., July 10, 2019 — Acutus Medical today announced the appointment of Scott Huennekens as Executive Chairman of the Board of Directors. Mr.
Funding Will Accelerate Commercialization and Facilitate Global Business Development Activities CARLSBAD, Calif., June 20, 2019 – Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility.